Lv has recognized that TP53, KRAS and APC are the most frequently earliest somatic mutations, and they are regarded as driver events for CRC; meanwhile other mutations such as CSMD3, TTN and ERBB4 as the latest mutations may contribute to CRC progression18. This evidence concerns the gene TP53 and colorectal carcinoma.